Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


11.06.2018

1 Br J Radiol
1 Can Urol Assoc J
1 Cancer Biomark
1 Cancer Nurs
1 Clin Chim Acta
2 Eur Rev Med Pharmacol Sci
1 Front Physiol
1 J Biosci
1 J Urol
1 Mol Ther Nucleic Acids
1 Onco Targets Ther
2 Oncotarget
1 PLoS One
1 Radiother Oncol
1 Res Rep Urol
1 Retin Cases Brief Rep
1 Tissue Cell
1 Toxicol Lett
2 Urol Oncol
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Radiol

  1. NAIK N, Lin M, Lin P
    Genitourinary involvement of lymphomas on FDG-PET.
    Br J Radiol. 2018;91:20170273.
    PubMed     Text format     Abstract available


    Can Urol Assoc J

  2. FAIREY AS, Mclarty R
    Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action.
    Can Urol Assoc J. 2018;12:187.
    PubMed     Text format    


    Cancer Biomark

  3. JIANG S, Tian F, Wang Q, Cheng W, et al
    High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.
    Cancer Biomark. 2018 May 25. pii: CBM181202. doi: 10.3233/CBM-181202.
    PubMed     Text format     Abstract available


    Cancer Nurs

  4. JUNG A, Nielsen ME, Crandell JL, Palmer MH, et al
    Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review.
    Cancer Nurs. 2018 Jun 1. doi: 10.1097/NCC.0000000000000606.
    PubMed     Text format     Abstract available


    Clin Chim Acta

  5. YU Y, Cao H, Zhang M, Shi F, et al
    Prognostic value of DNA methylation for bladder cancer.
    Clin Chim Acta. 2018;484:207-212.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  6. RAJWA P, Zyczkowski M, Paradysz A, Bujak K, et al
    Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy.
    Eur Rev Med Pharmacol Sci. 2018;22:3027-3037.
    PubMed     Text format     Abstract available

  7. DONG ZC, Zhang D, Wang SB, Lin ZQ, et al
    Target inhibition on GSK-3beta by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2018;22:3018-3026.
    PubMed     Text format     Abstract available


    Front Physiol

  8. WEBER L, Schulz WA, Philippou S, Eckardt J, et al
    Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer.
    Front Physiol. 2018;9:456.
    PubMed     Text format     Abstract available


    J Biosci

  9. ZHU Y, Liang S, Pan H, Cheng Z, et al
    Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.
    J Biosci. 2018;43:365-373.
    PubMed     Text format     Abstract available


    J Urol

  10. AUDENET F, Waingankar N, Ferket BS, Niglio SA, et al
    Effectiveness of transurethral resection (TUR) plus systemic chemotherapy as definitive treatment for muscle-invasive bladder cancer (MIBC) in population-level data.
    J Urol. 2018 Jun 4. pii: S0022-5347(18)43313-7. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


    Mol Ther Nucleic Acids

  11. JIN H, Sun W, Zhang Y, Yan H, et al
    MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer.
    Mol Ther Nucleic Acids. 2018;11:312-322.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  12. LI D, Hao X, Song Y
    An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
    Onco Targets Ther. 2018;11:3075-3085.
    PubMed     Text format     Abstract available


    Oncotarget

  13. WU SQ, Xu R, Li XF, Zhao XK, et al
    Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.
    Oncotarget. 2018;9:25294-25303.
    PubMed     Text format     Abstract available

  14. SNELL KIE, Ward DG, Gordon NS, Goldsmith JC, et al
    Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.
    Oncotarget. 2018;9:25244-25253.
    PubMed     Text format     Abstract available


    PLoS One

  15. XIA Y, Liu Z, Yu W, Zhou S, et al
    The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
    PLoS One. 2018;13:e0198602.
    PubMed     Text format     Abstract available


    Radiother Oncol

  16. CHRISTODOULOU M, Reeves KJ, Hodgson C, Zeniou A, et al
    Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.
    Radiother Oncol. 2018 Jun 2. pii: S0167-8140(18)30281.
    PubMed     Text format     Abstract available


    Res Rep Urol

  17. MEKAYTEN M, Yutkin V, Duvdevani M, Pode D, et al
    High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
    Res Rep Urol. 2018;10:33-38.
    PubMed     Text format     Abstract available


    Retin Cases Brief Rep

  18. WHALEN KE, Eagle RC Jr, Vrabec TR
    CASE OF METASTATIC UROTHELIAL CARCINOMA OF THE RETINA AND VITREOUS.
    Retin Cases Brief Rep. 2018;12:177-180.
    PubMed     Text format     Abstract available


    Tissue Cell

  19. DIAS LP, Luzo ACM, Volpe BB, Duran M, et al
    Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer.
    Tissue Cell. 2018;52:17-27.
    PubMed     Text format     Abstract available


    Toxicol Lett

  20. HUANG CY, Lin YC, Shiue HS, Chen WJ, et al
    Comparison of Arsenic Methylation Capacity and Polymorphisms of Arsenic Methylation Genes between Bladder Cancer and Upper Tract Urothelial Carcinoma.
    Toxicol Lett. 2018 May 30. pii: S0378-4274(18)30231.
    PubMed     Text format     Abstract available


    Urol Oncol

  21. DANESHMAND S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, et al
    Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30135.
    PubMed     Text format     Abstract available

  22. YANG GL, Zhang LH, Liu Q, Wang ZL, et al
    Commentary on "A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience."
    Urol Oncol. 2018 May 30. pii: S1078-1439(18)30164.
    PubMed     Text format     Abstract available


    World J Urol

  23. AUDENET F, Farkas AM, Anastos H, Galsky MD, et al
    Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 2. pii: 10.1007/s00345-018-2359.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: